Recent Updates in Cardiology for Consultant Pharmacists

Program Details

  • Intended Audience: Consultant pharmacists or pharmacists interested in cardiology
  • UAN:0012-0000-19-015-H01-P
  • CE Hours: 3 Consultant Recertification
  • Price: $50
  • Dates Available: 05/07/2019 – 05/07/2022
  • Activity Type: Application
Enroll Now

Summary

This is an educational resource designed to help pharmacists develop a better knowledge of the recently published ACC hypertension and AHA/ACC dyslipidemia guidelines, as well as the recently published AHA/ACC/HRS focused update on atrial fibrillation.


Goals and Objectives

Part 1: Updates in Hypertension Management

The goal of this activity is to help pharmacists develop a better knowledge of the recently published ACC hypertension guidelines in order to provide safe and effective patient care.

Objectives

  • Define the stages of hypertension and the appropriate treatment methods
  • Describe the appropriate pharmacotherapy for management of hypertension
  • Summarize the appropriateness of antihypertensive therapy in a given patient

Module 2: Updates in Dyslipidemia

The goal of this activity is to help pharmacists develop a better knowledge of the recently published AHA/ACC dyslipidemia guidelines in order to provide safe and effective patient care.

Objectives

  • Review recent evidence-based lipid lowering guidelines.
  • Identify the mechanism of action and effect on lipids of the newly approved PCSK9 lipid lowering agents
  • Determine patient eligibility for lipid-lowering therapy
  • Select an approprite evidence-based lipid-lowering treatment plan

Module 3: Updates in Atrial Fibriliation

The goal of this activity is to help pharmacists develop a better understanding of atrial fibrillation and of the recently published AHA/ACC/HRS focused update on atrial fibrillation, in order to provide safe and effective patient care.

Objectives

The goal of this activity is to help pharmacists develop a better understanding of atrial fibrillation and of the recently published AHA/ACC/HRS focused update on atrial fibrillation, in order to provide safe and effective patient care.

  • Describe the pathophysiology and risk factors for atrial fibrillation
  • Compare and contrast the FDA approved oral anticoagulants for management of atrial fibrillation
  • Review the 2019 AHA/ACC/HRS Focused Updates for atrial fibrillation

Acknowledgements and Disclosures

The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.†

Mary Margaret Lenefsky, PharmD
Freelance Medical Communications Specialist/Writer

Priti Patel, PharmD, BCPS
Clinical Associate Professor
College of Pharmacy, University of Florida

Kristin Weitzel, Pharm.D., CDE, FAPhA
Associate Director, UF Health Personalized Medicine Program
Director, Continuing Pharmacy Education
Clinical Professor, Pharmacotherapy and Translational Research
University of Florida


Schedule of Activities

Review all three parts and pass all three post-tests with 70% or more.

Requirements for Successful Course Completion

Review the course material, receive a 70% or higher on all 3 post-tests, and complete an online program evaluation.

Credit Reporting

  • The University of Florida College of Pharmacy will report CPE credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.
  • All pharmacists and pharmacy technicians maintain their own license and/or certification and it is their responsibility to follow up with the Office of Continuing Education at the University of Florida if any CE credit discrepancies are found.
  • It is at the University’s discretion to award or deny credit to a late claiming participant (i.e. after 60 days of the participant engaging in a CPE activity) as it is the University’s CE activity and the provider needs to ensure the requirements necessary for credit are successfully completed.
  • The University may request access to CPE Monitor® if the activity in question occurred within the previous 6 months and with an appropriate reason for access, i.e. power outage, etc.

Program Financial Support

This course received no outside funding support.

Computer Requirements

Computer and Internet access are required to complete this course. Course content is provided via Canvas.

The minimum hardware, software, and Internet requirements for Canvas can be found here.

Policies

Refund Policy for CE Courses

Privacy and Confidentiality Policy

Copyright

This course in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.

For questions or more information, please contact our office.


ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.